These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1726 related items for PubMed ID: 19468078

  • 1. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E, Canfell K.
    Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078
    [Abstract] [Full Text] [Related]

  • 2. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP.
    Am J Obstet Gynecol; 2004 Apr 01; 190(4):1141-67. PubMed ID: 15118656
    [Abstract] [Full Text] [Related]

  • 3. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
    Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.
    Am J Epidemiol; 2009 Jul 01; 170(1):12-23. PubMed ID: 19468079
    [Abstract] [Full Text] [Related]

  • 4. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD.
    Ann N Y Acad Sci; 2005 Jun 01; 1052():57-74. PubMed ID: 16024751
    [Abstract] [Full Text] [Related]

  • 5. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr 01; 12(64):65-9. PubMed ID: 12674130
    [Abstract] [Full Text] [Related]

  • 6. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F, Manson JE, Stampfer MJ.
    J Womens Health (Larchmt); 2006 Apr 01; 15(1):35-44. PubMed ID: 16417416
    [Abstract] [Full Text] [Related]

  • 7. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
    Henderson VW.
    Neuroscience; 2006 Apr 01; 138(3):1031-9. PubMed ID: 16310963
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM, Naftolin F, Brinton EA, Judelson DR.
    Ann N Y Acad Sci; 2005 Jun 01; 1052():43-56. PubMed ID: 16024750
    [Abstract] [Full Text] [Related]

  • 13. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA, Margolis K, Luepker RV, Arnett DK.
    J Womens Health (Larchmt); 2004 Nov 01; 13(9):975-85. PubMed ID: 15665654
    [Abstract] [Full Text] [Related]

  • 14. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM, Chung TK, Haines C.
    Gynecol Endocrinol; 2005 Nov 01; 21(5):248-56. PubMed ID: 16373243
    [Abstract] [Full Text] [Related]

  • 15. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?
    Manson JE, Bassuk SS.
    Am J Epidemiol; 2007 Sep 01; 166(5):511-7. PubMed ID: 17646204
    [Abstract] [Full Text] [Related]

  • 16. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 01; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 17. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA, Nahum GG, Stanislaw H, Gaines T.
    Maturitas; 2010 Jul 21; 66(3):277-84. PubMed ID: 20471761
    [Abstract] [Full Text] [Related]

  • 20. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO, Al-Azzawi F, Barlow D, Calaf-Alsina Erdogan Ertüngealp J, Gompel A, Graziottin A, Hudita D, Pines A, Rozenberg S, Samsioe G, Stevenson JC, European Menopause and Andropause Society.
    Maturitas; 2005 May 16; 51(1):8-14. PubMed ID: 15883103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 87.